- Home
- ARKO vs PRTA Comparison
ARKO vs PRTA Comparison
Compare ARKO & PRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARKO
- PRTA
- Stock Information
- Founded
- ARKO 1970
- PRTA 2012
- Country
- ARKO United States
- PRTA Ireland
- Employees
- ARKO N/A
- PRTA N/A
- Industry
- ARKO Oil Refining/Marketing
- PRTA Biotechnology: Pharmaceutical Preparations
- Sector
- ARKO Energy
- PRTA Health Care
- Exchange
- ARKO Nasdaq
- PRTA Nasdaq
- Market Cap
- ARKO 819.7M
- PRTA 765.2M
- IPO Year
- ARKO N/A
- PRTA N/A
- Fundamental
- Price
- ARKO $7.55
- PRTA $15.56
- Analyst Decision
- ARKO Hold
- PRTA Buy
- Analyst Count
- ARKO 2
- PRTA 8
- Target Price
- ARKO $6.13
- PRTA $46.00
- AVG Volume (30 Days)
- ARKO 523.6K
- PRTA 336.3K
- Earning Date
- ARKO 02-26-2025
- PRTA 02-20-2025
- Dividend Yield
- ARKO 1.59%
- PRTA N/A
- EPS Growth
- ARKO N/A
- PRTA N/A
- EPS
- ARKO 0.16
- PRTA N/A
- Revenue
- ARKO $8,973,013,000.00
- PRTA $135,157,000.00
- Revenue This Year
- ARKO N/A
- PRTA $56.89
- Revenue Next Year
- ARKO N/A
- PRTA N/A
- P/E Ratio
- ARKO $47.72
- PRTA N/A
- Revenue Growth
- ARKO N/A
- PRTA 47.92
- 52 Week Low
- ARKO $4.09
- PRTA $11.70
- 52 Week High
- ARKO $8.09
- PRTA $31.03
- Technical
- Relative Strength Index (RSI)
- ARKO 60.90
- PRTA 59.65
- Support Level
- ARKO $7.45
- PRTA $13.69
- Resistance Level
- ARKO $7.82
- PRTA $15.09
- Average True Range (ATR)
- ARKO 0.32
- PRTA 0.91
- MACD
- ARKO 0.07
- PRTA 0.13
- Stochastic Oscillator
- ARKO 77.95
- PRTA 68.56
About ARKO ARKO Corp.
ARKO Corp owns and operates convenience stores in the United States. Some of its regional store brands include Stop, Admiral, Apple Market, BreadBox, E-Z Mart, fas mart, Li'l Cricket, and Next Door Store. Its retail store offers hot food service, beverages, cigarettes & other tobacco products, candy, salty snacks, grocery, beer, and general merchandise. ARKO operates in four segments: Retail segment, Wholesale segment, fleet fueling segment, and GPM Petroleum segment. The company derives the majority of its revenue from retail and wholesale distribution of fuel.
About PRTA Prothena Corporation plc
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).